Literature DB >> 8322453

Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.

M Okada1, K Yoshioka, T Takemura, N Akano, N Aya, K Murakami, S Maki.   

Abstract

The localization of C3d, a fragment produced by C3 activation and S-protein (vitronectin), a regulatory factor of C5b-9, was studied immunohistochemically in normal human kidney and renal biopsies from patients with several types of glomerulonephritis. Immunofluorescent staining of the normal kidneys showed that C3d was present along the glomerular basement membrane (GBM), tubular basement membrane (TBM) and arterioles, and that S-protein was present in the GBM, mesangium, TBM, and arterioles. Immunoelectron microscopy of isolated basement membranes showed that C3d was localized exclusively on the epithelial side of the GBM, and that S-protein was present along both the epithelial and endothelial sides. In nephritic tissues, glomerular staining of C3d, C5b-9, and S-protein was increased when compared with that in normal tissues. S-protein, frequently co-localized with C3d and C5b-9 neoantigen, was intensely positive in the immune deposits of glomerular capillaries and the mesangial area, overlapping the background staining of GBM and mesangial matrix. S-protein and its receptor were occasionally co-localized in the glomeruli. These findings indicate that C3d and S-protein are normally present in the glomeruli. Co-staining of C3d, C5b-9 neoantigen, and S-protein within the immune deposits of nephritic kidneys suggests in situ binding of S-protein to locally-formed C5b-9 complex, or merely co-distribution of S-protein with the complex, rather than trapping of large molecular SC5b-9 complex from the circulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322453     DOI: 10.1007/bf01605455

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  21 in total

1.  Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function.

Authors:  J A Madri; M D Basson
Journal:  Lab Invest       Date:  1992-05       Impact factor: 5.662

2.  Identification and localization of epidermal growth factor and its receptor in the human glomerulus.

Authors:  K Yoshioka; T Takemura; K Murakami; N Akano; K Matsubara; N Aya; S Maki
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

3.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.

Authors:  J Bariety; N Hinglais; S Bhakdi; C Mandet; M Rouchon; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Activation of the alternative complement pathway by isolated human glomerular basement membrane.

Authors:  J D Williams; J K Czop; D R Abrahamson; M Davies; K F Austen
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Glomerular localization of type III collagen in human kidney disease.

Authors:  K Yoshioka; T Takemura; M Tohda; N Akano; H Miyamoto; A Ooshima; S Maki
Journal:  Kidney Int       Date:  1989-05       Impact factor: 10.612

6.  Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy.

Authors:  Y Tomino; M Yagame; K Eguchi; Y Nomoto; H Sakai
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

7.  Characterization of tubular basement membrane antigens in human kidney.

Authors:  K Yoshioka; Y Morimoto; T Iseki; S Maki
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

8.  The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor.

Authors:  G Biesecker
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

9.  Immunohistochemical study of the C5b-9 complex of complement in human kidneys.

Authors:  N Hinglais; M D Kazatchkine; S Bhakdi; M D Appay; C Mandet; J Grossetete; J Bariety
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

10.  Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.

Authors:  P J Lachmann; M K Pangburn; R G Oldroyd
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

3.  Alterations in extracellular matrix components and integrins in patients with preeclamptic nephropathy.

Authors:  H Shiiki; T Nishino; H Uyama; T Kimura; K Nishimoto; T Hashimoto; Y Fujii; K Dohi
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

4.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.

Authors:  Guangzhen Fu; Ye Du; Lina Chu; Man Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-03

6.  Targeting of exon VI-skipping human RGR-opsin to the plasma membrane of pigment epithelium and co-localization with terminal complement complex C5b-9.

Authors:  Harold Kochounian; Zhaoxia Zhang; Christine Spee; David R Hinton; Henry K W Fong
Journal:  Mol Vis       Date:  2016-03-03       Impact factor: 2.367

Review 7.  Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.

Authors:  Jacob J E Koopman; Mieke F van Essen; Helmut G Rennke; Aiko P J de Vries; Cees van Kooten
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

8.  Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin.

Authors:  Thuzar M Shin; J Mario Isas; Chia-Ling Hsieh; Rakez Kayed; Charles G Glabe; Ralf Langen; Jeannie Chen
Journal:  Mol Neurodegener       Date:  2008-10-21       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.